JUSTIN STONE: Open Payments
NPI 1346762580 · BEDFORD, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$554 in 23 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $400 · 2025 $554
Food & beverage: $554
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 7 | $167 |
| Otsuka America Pharmaceutical, Inc. | 4 | $97 |
| Teva Pharmaceuticals USA, Inc. | 3 | $73 |
| E.R. Squibb & Sons, L.L.C. | 3 | $62 |
| Axsome Therapeutics, Inc. | 2 | $54 |
| Janssen Pharmaceuticals, Inc | 1 | $42 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $34 |
| Neurocrine BioSciences, Inc. | 1 | $24 |
Products named: ARISTADA, ABILIFY ASIMTUFII, COBENFY, LYBALVI, Auvelity, UZEDY, INVEGA SUSTENNA, CAPLYTA.
Industry payments across NH — which companies pay providers there.
